Converging on Cures:
Nodal Biology meets
Transformative Technology

3RD ANNUAL LADDERS TO CURES SYMPOSIUM

OCTOBER 27, 2026

8:30AM - 6:00PM ET

BROAD INSTITUTE OF MIT AND HARVARD

AND STREAMING ONLINE

9:10 - 9:55am

SESSION 1 | Scaling Rare Disease Therapeutics: Disease-Agnostic Editing, Patient Data, and Clinical-Stage Pipelines

9:10am Disease agnostic editing modalities | David Liu (Broad Institute)

9:35am Patient Data as a Drug Development Engine: Lessons from FOXG1 | Nasha Fitter (Citizen Health)

9:55 - 10:30am PANEL 1 | Advancing Clinical-Stage Assets

Moderator David Meeker (Rhythm Pharmaceuticals)

Panelists: Meg Alexander (Ovid Therapeutics), David Goldstein (Actio Biosciences), Winston Yan (N=1; Center for Therapeutic Genetics)

10:30 - 10:45 am Coffee Break/Networking

10:45 - 11:30am

SESSION 2 | AI-Driven Target Discovery and Drug Design Chair: Caroline Uhler (Broad)

10:45 - 11:05am Optical Pooled Screening and AI-driven Target Discovery | Olivia Wiles (Google Deep Mind) + Matt Brown (Broad Institute)

11:05 - 11:30am From Target Discovery to Clinical Impact | Andrew Adams (Eli Lilly)

11:30 - 11:55am

SESSION 3 | Metabolic Nodes as Therapeutic Targets in Mitochondrial Disease Chair: Jillian Shaw

11:30 - 11:55am Hypoxia as a Nodal Therapeutic Strategy for Mitochondrial Diseases | Vamsi Mootha

11:55 - 1:00 pm Lunch/Networking

1:00 - 2:00pm

SESSION 4 | Mechanism-Driven Small-Molecule Discovery Chair: Raj Gupta

1:00 - 1:20pm Small-molecule Discovery for Microvillus Inclusion Disease |

Jay Thiagarjah (BCH/Tools-to-Therapies Investigator)

1:20 - 1:40pm Scalable Screening Approaches for Rare Pediatric Kidney Disease |

Magdalena Riedl Khursigara (Broad Institute; Tools-to-Therapies Investigator)

1:40 - 2:00pm Generalizable approaches to Collagenopathies: proteostasis as a nodal target across connective tissue disorders | Christina Jacobsen (BCH)

2:00 - 2:40pm

SESSION 5 | Scalable Cell Platforms for Disease Modeling and Screening

Chair: Stacey Gabriel (Broad Institute)

2:00 - 2:20pm Cellular Barcoding at Scale: Mapping Rare Cardiovascular Disease Mechanisms with iPSCs

Sarah Morton (BCH/Broad Institute)

2:20 - 2:40pm CellWorks: Cell Line Engineering and High-Throughput Screening |

Sarra Merzouk (Broad Institute/Tools-to-Therapies/CellWorks)

2:40 - 3:00pm Coffee + Networking Break

3:00 - 3:15pm CNBC Cures: Becky Quick in Conversation with Anna Greka

3:15 - 3:50pm

PANEL 2 | The Reimbursement Gap: Can the Economics of Rare Diseases Keep Pace with

Scientific Discovery?

Moderator: Annie Kennedy (RARE Foundation), Panelists: Andrew Lo (MIT), William Shrank (Aradigm), Duncan McKechnie, Ekemini Riley (Coalition for Aligning Science)

3:50 - 4:25pm

PANEL 3 | Clearing the Path: How Advocates and Regulators Get Rare Disease Therapies Approved

Moderator: Charlene Son Rigby (Global Genes)

Panelists: Cat Lutz (Jackson Laboratory), Terry Pirovolakis (Elpida Therapeutics), Sunitha Malepati

4:25 - 4:30pm Concluding Remarks | Anna Greka

4:30 - 6:00pm Poster Session, Reception, Networking

8:30am Registration

8:50am Opening Remarks | Todd Golub

9:00am State of the L2C Scientific Accelerator | Anna Greka and Jillian Shaw

Speakers

  • Andrew Adams, PhD

    Eli Lilly and Company

  • Christina Jacobsen, MD, PhD

    Boston Children’s Hospital

  • David Liu, PhD

    Broad Institute

  • Magdalena Riedl Khursigara, MD, PhD

    Broad Institute

  • Nasha Fitter, MBA

    Citizen Health

  • Sarah Morton, MD, PhD

    Boston Children’s Hospital

  • Vamsi Mootha, MD

    Broad Institute

  • Annie Kennedy

    RARE Foundation

  • Sunitha Malepati

    Renaissance Philanthropy

FAQs

FAQs